Summit Therapeutics' potential breakthrough targets C.difficile
15.00 Fri 27 Nov 2020
Open Orphan: Sustaining commercial traction
Open Orphan PLC, a specialist pharmaceutical services company, and the world leader in...
In the six-month period to June 2020, ORPH focused on integration and restructuring...
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.